课题基金 / 基金详情

Frontiers: University of Kansas Clinical and Translational Science Institute

Frontiers: University of Kansas Clinical and Translational Science Institute
前沿:堪萨斯大学临床与转化科学研究所
批准号:
10474055
负责人:
Mario Castro
金额:
$121.15万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-07 至 2022-12-31
关键词:
AcademiaAddressAdvocacyAdvocateAfrican AmericanAmerican IndiansAutomobile DrivingAwardBirthChildhoodCitiesClinicClinicalClinical ResearchClinical SciencesCollaborationsCommunitiesCompetenceComplexDataData AnalysesDecision MakingDevelopmentDisciplineDiseaseElderlyElectronic Health RecordEnsureEntrepreneurshipEthicsFundingGenerationsGoalsGood Clinical PracticeGovernmentHealthHealth SciencesHealthcareIndividualIndustryInformaticsInformation DisseminationInfrastructureInstitutesInstitutionInstitutional Review BoardsInterdisciplinary StudyKansasKnowledgeLatinoLeadLeadershipLesbian Gay Bisexual Transgender QueerLinkLongevityMedicalMedical DeviceMedical InformaticsMedical centerMethodsMidwestern United StatesParticipantPatient RecruitmentsPatientsPharmaceutical PreparationsPilot ProjectsPopulation HeterogeneityPositioning AttributeProcessRare DiseasesRegistriesResearchResearch DesignResearch InfrastructureResearch PersonnelResearch SupportResearch TrainingResource InformaticsResourcesRural PopulationScienceScientific Advances and AccomplishmentsTexasTrainingTraining ProgramsTranslatingTranslational ResearchUniversitiesVisionWorkforce Developmentbasecatalystclinical carecommunity engagementcommunity partnershipdrug discoveryend of lifefrontierimplementation researchimprovedindustry partnerinformatics toolinnovationmulti-site trialmultidisciplinarynext generationnovelnovel strategiespatient engagementpatient orientedpoint of carepopulation healthprecision medicineprison populationproduct developmentprogramsrecruitservice organizationsupport toolstool

项目摘要

项目成果

Mario Castro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Abstract Local health departments are employing widely varying approaches to address the dramatic health inequities associated with the COVID-19 pandemic. Learning collaboratives have been effective in other settings for bringing entities together to support joint problem solving and reduce variance in approach. These collaboratives build upon shared experiences to help their members understand not only what to do but how to do it, providing knowledge and skills that are critical to successful implementation of interventions. This study aims to examine the effectiveness of a diverse, regional learning collaborative of health departments that will rapidly adapt, test, and implement community-driven solutions for COVID testing disparities using a pragmatic, hybrid type II trial design. Based on preliminary data from a community-led approach developed in a severely affected Kansas county (Wyandotte), the project will build Local Heath Equity Action Teams in 10 counties (4 urban and 6 rural) disproportionately affected by COVID and provide them with the training and resources needed to achieve COVID testing equity. These Local Health Equity Action Teams will come together into a multi-jurisdictional learning collaborative or `Community Partner Program' (Aim 1) that can share best practices and collaborate on developing, testing and evaluating multi-component intervention packages for addressing COVID. Initial supported interventions will include: community-sponsored pop-up testing events; home-based and worksite testing; community-informed communication strategies; and `support packages' for at-risk individuals and families receiving testing. Additional interventions developed or proposed by our local community partners or identified through national RADx-UP efforts will be continuously considered by the collaborative. Working with the local Action teams, we will conduct a series of semi-structured interviews and surveys within each local community (Aim 2) to better understand common and subgroup (racial, ethnic, geographic, etc.) barriers to and facilitators of testing. We will leverage existing epidemiologic surveillance tools to develop and track a series of county-level metrics of COVID testing inequities. Guided by the RE-AIM framework and the Consolidated Framework for Intervention Research, we will examine the effectiveness (Aim 3) of the collaborative in improving uptake of COVID testing in vulnerable communities and examine the reach, adoption, implementation and maintenance of intervention components within each local community. This study will not only advance our understanding of how to achieve COVID testing equity but will also provide a framework for supporting underserved communities as they respond to future public health emergencies and COVID vaccination challenges.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Kansas' Precision Biologic Interventions for Severe Exacerbation Prone Asthma (PrecISE) Clinical Center
University of Kansas' Precision Biologic Interventions for Severe Exacerbation Prone Asthma (PrecISE) Clinical Center
WASHINGTON UNIVERSITY'S PRECISION BIOLOGIC INTERVENTIONS FOR SEVERE EXACERBATION PRONE ASTHMA (PRECISE) CLINICAL CENTER
  • 批准号:
    9751957
  • 项目类别:
  • 资助金额:
    $6.53万
  • 财政年份:
    2017
  • 负责人:
    Mario Castro
  • 依托单位:
Frontiers Clinical and Translational Science Institute at the University of Kansas
海外基金